Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Ask the Doctor Question:
What is the PFS for those on ibrutinib who have reached U-MRD and took a drug holiday?
Answer: There are no data, but there are anecdotal reports of patients going years without further treatment.
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
One click to our most popular content.
